Clover Health Reports Robust Financial Growth and Provides 2025 Outlook

Clover Health's insurance revenue for the fourth quarter reached $331 million, marking a 9% increase year-over-year. For the entire year, the company reported total insurance revenue of $1.3 billion, also a 9% increase compared to 2023. This growth can primarily be attributed to strong member retention and effective cohort management.

The company's financial performance for the fourth quarter showed marked improvements, with GAAP net loss from continuing operations narrowing to $21 million, a significant reduction from the $68 million loss in the same quarter of 2023. Adjusted net income from continuing operations turned positive at $7 million, compared to a loss of $22 million in the fourth quarter of the previous year. Adjusted EBITDA also experienced a turnaround, coming in at a profit of $8 million, up from a loss of $17 million in Q4 2023.

For the full year 2024, the GAAP net loss from continuing operations decreased dramatically to $46 million, compared to a loss of $210 million in 2023. The adjusted net income for the year was $68 million, a substantial improvement over the $49 million loss recorded in the previous year. Additionally, Clover Health achieved an adjusted EBITDA of $70 million for 2024, reversing a $42 million loss in 2023.

Clover's insurance benefit expense ratio (BER) improved significantly, reaching 82.8% in the fourth quarter, down from 87.4% in Q4 2023. For the full year, the BER also improved to 81.2% from 86.5% the year prior. The company's focus on operational efficiency is reflected in its salaries and benefits, as well as general and administrative expenses, which decreased by 7.1% for the full year.

Clover Health CEO Andrew Toy remarked, “2024 was a pivotal year for us as we demonstrated that our technology-first physician empowerment model, combined with our ability to directly manage members via our home care arm, achieves differentiated clinical and financial results.” He emphasized confidence in the company’s ability to maintain exceptional management of its membership cohorts, which is expected to drive further growth and profitability.

Clover Health is optimistic about its prospects for 2025, providing a comprehensive financial outlook:

As of December 31, 2024, Clover Health reported 82,664 insurance members, a slight increase from 81,205 members in 2023. This growth illustrates the effectiveness of Clover’s strategies and its commitment to enhancing patient care through technology and personalized services.

Clover Health’s CFO, Peter Kuipers, noted, “With this momentum, we are well positioned in 2025 and beyond to invest in new membership growth and Clover Assistant technology, while maintaining strong Adjusted EBITDA profitability.”

Clover Health's fourth quarter and full-year results for 2024 paint a picture of a company on the upswing, characterized by improved financial metrics, operational efficiencies, and a clear strategic vision for growth. As Clover Health moves into 2025, stakeholders will be closely watching its execution of the outlined strategies to capitalize on its competitive position in the healthcare market. The upcoming conference call scheduled for 5:00 p.m. ET will likely provide further insights into the company’s operational strategies and future initiatives.